During the morning session, innovative drug stocks experienced a downturn, with Rongchang Biotech's share price plunging, at one point nearing the daily limit down. Other companies, including Onlycon, Hotgen Biotech, STS Biopharma, and Yuekang Pharmaceutical, also saw significant declines in their stock prices.